Sunopta (SOY.TO) Stock Price
Sunopta Price
Over the last 19 years Sunopta grew revenue by 2.8% annually, reaching 725.43 M USD. Earnings per share have grown at 7.9% per year over the last 15 years. For Sunopta, the net margin of -2.5% is down versus 8.5% a few years ago. The consensus 12-month price target for Sunopta is 7.98 USD, about 23.6% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus. Sunopta's share price has gained 24.5% over the last twelve months. The stock trades about 86% above its 52-week low.
Sunopta stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Sunopta over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sunopta stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sunopta's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Sunopta Price |
|---|---|
| 5/6/2026 | 6.45 USD |
| 5/5/2026 | 6.45 USD |
| 5/4/2026 | 6.42 USD |
| 5/1/2026 | 6.26 USD |
| 4/30/2026 | 6.45 USD |
| 4/29/2026 | 6.46 USD |
| 4/28/2026 | 6.48 USD |
| 4/27/2026 | 6.48 USD |
| 4/24/2026 | 6.45 USD |
| 4/23/2026 | 6.47 USD |
| 4/22/2026 | 6.48 USD |
| 4/21/2026 | 6.48 USD |
| 4/20/2026 | 6.48 USD |
| 4/17/2026 | 6.48 USD |
| 4/16/2026 | 6.51 USD |
| 4/15/2026 | 6.49 USD |
| 4/14/2026 | 6.51 USD |
| 4/13/2026 | 6.51 USD |
| 4/10/2026 | 6.56 USD |
| 4/9/2026 | 6.57 USD |
| 4/8/2026 | 6.56 USD |
| 4/7/2026 | 6.59 USD |
| 4/6/2026 | 6.58 USD |
| 4/2/2026 | 6.61 USD |
| 4/1/2026 | 6.59 USD |
| 3/31/2026 | 6.59 USD |
| 3/30/2026 | 6.61 USD |
| 3/27/2026 | 6.57 USD |
| 3/26/2026 | 6.56 USD |
| 3/25/2026 | 6.55 USD |
| 3/24/2026 | 6.51 USD |
| 3/23/2026 | 6.49 USD |
| 3/20/2026 | 6.49 USD |
| 3/19/2026 | 6.47 USD |
| 3/18/2026 | 6.49 USD |
| 3/17/2026 | 6.48 USD |
| 3/16/2026 | 6.43 USD |
| 3/13/2026 | 6.43 USD |
| 3/12/2026 | 6.38 USD |
| 3/11/2026 | 6.42 USD |
| 3/10/2026 | 6.40 USD |
| 3/9/2026 | 6.40 USD |
| 3/6/2026 | 6.42 USD |
| 3/5/2026 | 6.44 USD |
| 3/4/2026 | 6.45 USD |
| 3/3/2026 | 6.45 USD |
| 3/2/2026 | 6.46 USD |
| 2/27/2026 | 6.41 USD |
| 2/26/2026 | 6.37 USD |
| 2/25/2026 | 6.41 USD |
| 2/24/2026 | 6.44 USD |
| 2/23/2026 | 6.43 USD |
| 2/20/2026 | 6.42 USD |
| 2/19/2026 | 6.39 USD |
| 2/18/2026 | 6.40 USD |
| 2/17/2026 | 6.37 USD |
| 2/13/2026 | 6.39 USD |
| 2/12/2026 | 6.40 USD |
| 2/11/2026 | 6.37 USD |
| 2/10/2026 | 6.34 USD |
| 2/9/2026 | 6.34 USD |
| 2/6/2026 | 6.38 USD |
| 2/5/2026 | 4.86 USD |
| 2/4/2026 | 4.89 USD |
| 2/3/2026 | 4.79 USD |
| 2/2/2026 | 4.68 USD |
| 1/30/2026 | 4.54 USD |
| 1/29/2026 | 4.51 USD |
| 1/28/2026 | 4.54 USD |
| 1/27/2026 | 4.72 USD |
| 1/26/2026 | 4.73 USD |
| 1/23/2026 | 4.83 USD |
| 1/22/2026 | 4.94 USD |
| 1/21/2026 | 4.82 USD |
| 1/20/2026 | 4.80 USD |
| 1/19/2026 | 4.69 USD |
| 1/16/2026 | 4.72 USD |
| 1/15/2026 | 4.74 USD |
| 1/14/2026 | 4.52 USD |
| 1/13/2026 | 4.56 USD |
| 1/12/2026 | 4.25 USD |
| 1/9/2026 | 3.79 USD |
| 1/8/2026 | 3.78 USD |
| 1/7/2026 | 3.73 USD |
| 1/6/2026 | 3.71 USD |
| 1/5/2026 | 3.61 USD |
| 1/2/2026 | 3.73 USD |
| 12/31/2025 | 3.82 USD |
| 12/30/2025 | 3.86 USD |
| 12/29/2025 | 3.84 USD |
| 12/24/2025 | 3.79 USD |
| 12/23/2025 | 3.67 USD |
| 12/22/2025 | 3.75 USD |
| 12/19/2025 | 3.74 USD |
| 12/18/2025 | 3.84 USD |
| 12/17/2025 | 3.83 USD |
| 12/16/2025 | 3.85 USD |
| 12/15/2025 | 3.87 USD |
| 12/12/2025 | 3.80 USD |
| 12/11/2025 | 3.88 USD |
| 12/10/2025 | 3.94 USD |
| 12/9/2025 | 3.80 USD |
| 12/8/2025 | 3.73 USD |
| 12/5/2025 | 3.64 USD |
| 12/4/2025 | 3.87 USD |
| 12/3/2025 | 3.83 USD |
| 12/2/2025 | 3.75 USD |
| 12/1/2025 | 3.77 USD |
| 11/28/2025 | 3.88 USD |
| 11/27/2025 | 3.74 USD |
| 11/26/2025 | 3.67 USD |
| 11/25/2025 | 3.47 USD |
| 11/24/2025 | 3.48 USD |
| 11/21/2025 | 3.55 USD |
| 11/20/2025 | 3.53 USD |
| 11/19/2025 | 3.65 USD |
| 11/18/2025 | 3.73 USD |
| 11/17/2025 | 3.80 USD |
| 11/14/2025 | 4.23 USD |
| 11/13/2025 | 4.30 USD |
| 11/12/2025 | 4.31 USD |
| 11/11/2025 | 4.28 USD |
| 11/10/2025 | 4.02 USD |
| 11/7/2025 | 4.06 USD |
| 11/6/2025 | 4.02 USD |
| 11/5/2025 | 5.43 USD |
| 11/4/2025 | 5.45 USD |
| 11/3/2025 | 5.37 USD |
| 10/31/2025 | 5.37 USD |
| 10/30/2025 | 5.43 USD |
| 10/29/2025 | 5.54 USD |
| 10/28/2025 | 5.61 USD |
| 10/27/2025 | 5.75 USD |
| 10/24/2025 | 5.87 USD |
| 10/23/2025 | 5.91 USD |
| 10/22/2025 | 6.01 USD |
| 10/21/2025 | 5.93 USD |
| 10/20/2025 | 5.86 USD |
| 10/17/2025 | 5.83 USD |
| 10/16/2025 | 5.75 USD |
| 10/15/2025 | 5.94 USD |
| 10/14/2025 | 5.86 USD |
| 10/10/2025 | 5.77 USD |
| 10/9/2025 | 5.91 USD |
| 10/8/2025 | 6.09 USD |
| 10/7/2025 | 6.02 USD |
| 10/6/2025 | 6.02 USD |
| 10/3/2025 | 6.19 USD |
| 10/2/2025 | 5.99 USD |
| 10/1/2025 | 6.00 USD |
| 9/30/2025 | 5.94 USD |
| 9/29/2025 | 5.94 USD |
| 9/26/2025 | 5.96 USD |
| 9/25/2025 | 5.96 USD |
| 9/24/2025 | 6.13 USD |
| 9/23/2025 | 6.15 USD |
| 9/22/2025 | 6.16 USD |
| 9/19/2025 | 6.26 USD |
| 9/18/2025 | 6.47 USD |
| 9/17/2025 | 6.34 USD |
| 9/16/2025 | 6.47 USD |
| 9/15/2025 | 6.46 USD |
| 9/12/2025 | 6.33 USD |
| 9/11/2025 | 6.45 USD |
| 9/10/2025 | 6.31 USD |
| 9/9/2025 | 6.53 USD |
| 9/8/2025 | 6.52 USD |
| 9/5/2025 | 6.65 USD |
| 9/4/2025 | 6.48 USD |
| 9/3/2025 | 6.32 USD |
| 9/2/2025 | 6.22 USD |
| 8/29/2025 | 6.26 USD |
| 8/28/2025 | 6.37 USD |
| 8/27/2025 | 6.37 USD |
| 8/26/2025 | 6.40 USD |
| 8/25/2025 | 6.44 USD |
| 8/22/2025 | 6.51 USD |
| 8/21/2025 | 6.26 USD |
| 8/20/2025 | 6.18 USD |
| 8/19/2025 | 6.32 USD |
| 8/18/2025 | 6.34 USD |
| 8/15/2025 | 6.18 USD |
| 8/14/2025 | 6.21 USD |
| 8/13/2025 | 6.34 USD |
| 8/12/2025 | 6.40 USD |
| 8/11/2025 | 6.28 USD |
| 8/8/2025 | 6.28 USD |
| 8/7/2025 | 6.18 USD |
| 8/6/2025 | 5.18 USD |
Sunopta Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Sunopta Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.10 | 1.15 | 1.35 | 1.28 | 0.78 | 0.72 | 0.79 | 0.81 | 0.93 | 0.63 | 0.73 | 0.82 | 0.84 | 0.93 | 1.03 | 1.11 |
| 10.42 | 3.90 | 17.55 | -4.98 | -38.70 | -8.04 | 9.43 | 2.92 | 15.02 | -32.55 | 15.08 | 12.41 | 3.07 | 10.36 | 11.33 | 7.07 |
| 11.07 | 9.61 | 9.36 | 11.57 | 9.69 | 9.02 | 14.07 | 12.19 | 14.35 | 20.16 | 16.41 | 16.41 | 16.41 | 16.41 | 16.41 | 16.41 |
| 122.00 | 110.00 | 126.00 | 148.00 | 76.00 | 65.00 | 111.00 | 99.00 | 134.00 | 127.00 | 119.00 | 133.77 | 137.88 | 152.16 | 169.39 | 181.37 |
| 41.00 | 18.00 | 14.00 | 8.00 | -18.00 | -22.00 | 13.00 | 17.00 | 34.00 | 51.00 | 40.00 | 22.00 | 23.00 | 26.00 | 29.00 | 31.00 |
| 3.72 | 1.57 | 1.04 | 0.63 | -2.30 | -3.05 | 1.65 | 2.09 | 3.64 | 8.10 | 5.52 | 2.70 | 2.74 | 2.80 | 2.81 | 2.81 |
| 13.00 | -22.00 | -53.00 | -143.00 | -117.00 | -8.00 | 67.00 | -5.00 | -8.00 | -176.00 | -17.00 | 17.00 | 22.00 | 36.00 | 46.00 | 60.00 |
| -262.50 | -269.23 | 140.91 | 169.81 | -18.18 | -93.16 | -937.50 | -107.46 | 60.00 | 2,100.00 | -90.34 | -200.00 | 29.41 | 63.64 | 27.78 | 30.43 |
| 68.40 | 72.40 | 85.60 | 86.40 | 87.10 | 87.80 | 89.20 | 104.10 | 107.70 | 114.23 | 116.62 | 116.62 | 116.62 | 116.62 | 116.62 | 116.62 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Sunopta generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sunopta retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sunopta's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Sunopta has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sunopta's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Sunopta stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Sunopta Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Sunopta business model & stock analysis
Sunopta SWOT Analysis
Strengths
1. Diverse product portfolio, including organic and non-GMO food products.
2. Strong brand reputation for high-quality and healthy food offerings.
3. Global presence with operations spanning across North America, Europe, and Asia.
Weaknesses
1. Vulnerability to fluctuations in commodity prices, especially for raw materials.
2. Limited financial resources compared to larger competitors in the industry.
3. High dependence on third-party suppliers for sourcing raw materials.
Opportunities
1. Growing consumer demand for organic and healthier food options globally.
2. Increasing focus on sustainable and environmentally-friendly practices.
3. Expansion into emerging markets with rising middle-class population.
Threats
1. Intense competition from both large food corporations and small specialty brands.
2. Changes in government regulations and policies related to food safety and labeling.
3. Economic downturns impacting consumer spending and purchasing power.
Sunopta Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Sunopta historical P/E ratio, EBIT multiple, and P/S ratio
Sunopta annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Sunopta shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Sunopta forecasts and price targets in August 2026
Analyst Price Targets 2026Sunopta Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 2/9/2026 | Maintained | Buy | – | |
| 2/6/2026 | Downgrade | BuyHold | – | |
| 11/6/2025 | Maintained | Outperform | 31 | |
| 1/2/2025 | Maintained | Overweight | – | |
| 11/6/2024 | Maintained | Overweight | – | |
| 10/10/2024 | Maintained | Buy | – | |
| 3/5/2024 | Maintained | Buy | – | |
| 2/29/2024 | Maintained | Buy | 59 | |
| 2/29/2024 | Maintained | Outperform | – | |
| 11/9/2023 | Maintained | Outperform | – |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Sunopta Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 5/8/2024 | 0.04USD | - | 166.60 MUSD | - | 2024 Q1 |
| 2/28/2024 | 0.02USD | - | 173.08 MUSD | - | 2023 Q4 |
| 8/8/2023 | 0.03USD | - | 263.05 MUSD | - | 2023 Q2 |
| 5/9/2023 | 0.02USD | - | 253.72 MUSD | - | 2023 Q1 |
| 2/22/2023 | 0.01USD | - | 226.66 MUSD | - | 2022 Q4 |
| 11/10/2022 | 0.01USD | - | 232.92 MUSD | - | 2022 Q3 |
| 8/10/2022 | -0.00USD | - | 222.84 MUSD | - | 2022 Q2 |
| 5/12/2022 | -USD | - | 234.42 MUSD | - | 2022 Q1 |
| 2/24/2022 | 0.01USD | - | 210.26 MUSD | - | 2021 Q4 |
| 11/10/2021 | 0.00USD | - | 210.04 MUSD | - | 2021 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Sunopta stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Sunopta shareholder structure
| % | Name |
|---|---|
17.77282% | |
5.75041% | |
5.57985% | |
4.16731% | |
4.09079% | |
3.40855% |
Sunopta Beneficial Ownership Filings (SEC 13D/G)
Sunopta Executives and Management Board
15 members · avg. age 56 · 27 % women
Mr. Brian Kocher (55)
Chief Executive Officer, Director · since 2024
6.14 M USD
Management
Ms. Jill Barnett (51)
Chief Administrative Officer, General Counsel, Corporate Secretary
Mr. Greg Gaba (43)
Chief Financial Officer
Mr. Justin Kobler (44)
Senior Vice President - Supply Chain
Mr. Bryan Clark (52)
Senior Vice President - Research and Development and Quality Assurance
Ms. Lauren Mcnamara (42)
Senior Vice President - Business Management
Mr. Robert Duchscher (64)
Chief Information Officer
Board of Directors
Mr. R. Dean Hollis (64)
Independent Director
Ms. Leslie Starr (64)
Non-Executive Independent Chairman of the Board
Mr. Mahes Wickramasinghe (67)
Independent Director
Ms. Rebecca Fisher (61)
Independent Director
Mr. Diego Reynoso (49)
Independent Director
Dr. Albert Bolles (67)
Independent Director
Sunopta Supply Chain
Sunopta Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.27 | 0.68 | 0.57 | ||
| 2 | 0.09 | 0.60 | 0.49 | ||
| 3 | -0.49 | -0.12 | 0.39 | ||
| 4 | 0.33 | 0.45 | 0.34 | ||
| 5 | -0.07 | 0.25 | 0.32 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.26 | -0.77 | — | ||
| 2 | -0.08 | -0.69 | -0.67 | ||
| 3 | 0.27 | -0.87 | -0.53 | ||
| 4 | -0.03 | -0.84 | -0.52 | ||
| 5 | 0.09 | -0.01 | -0.51 |
Frequently asked questions about Sunopta
Sunopta Inc's business model centers around sourcing, processing, and distributing organic and specialty food products. As a leading global company, Sunopta operates through two key segments: Global Ingredients and Consumer Products. Through its Global Ingredients division, Sunopta supplies organic and non-genetically modified (non-GMO) ingredients to food manufacturers. Their Consumer Products segment focuses on selling natural and organic food products directly to retail consumers. By offering a wide range of organic and specialty food items, Sunopta Inc aims to meet the growing demand for healthy, sustainable, and clean-label food options worldwide.
Sunopta Inc is primarily active in the food and beverage industry.
The main competitors of Sunopta Inc in the market include Archer Daniels Midland Company, Ingredion Incorporated, and Nestlé S.A.
Sunopta Inc. is a company that specializes in organic and non-genetically modified food products. With a history dating back to 1973, Sunopta has established itself as a trusted provider of natural and organic ingredients globally. Over the years, it has expanded its product offerings and now operates in three business segments: Global Ingredients, Consumer Products, and Opta Minerals. Sunopta prides itself on its commitment to sustainable and healthy food options, providing customers with innovative and nutritious products. With its strong focus on quality and integrity, Sunopta Inc. has become a recognized name in the organic food industry.
Sunopta Inc, a leading global company, has achieved numerous significant milestones throughout its existence. Notably, the company has successfully expanded its presence in the organic and natural food industry, becoming a trusted provider of organic ingredients and packaged products. Sunopta has also established strategic partnerships and made key acquisitions to enhance its product portfolio and market reach. The company's dedication to sustainability and commitment to delivering high-quality, responsibly sourced products has earned it accolades and recognition within the industry. Sunopta Inc's ongoing focus on innovation, customer satisfaction, and continuous growth has solidified its position as a prominent player in the organic food sector.
Sunopta Inc is primarily present in North America, with operations in the United States and Canada. It has a significant presence in various regions throughout these countries, including the Midwest, Northeast, and West Coast of the United States, as well as the provinces of Ontario and Quebec in Canada. Sunopta Inc is a leading global company in the organic food industry, specializing in sourcing, processing, and distribution of organic and specialty food products. With its strong foothold in North America, Sunopta Inc continues to expand and cater to the growing demand for organic food products in the region.
Sunopta Inc represents values of integrity, transparency, and sustainability. The company is committed to providing natural and organic food products while promoting environmental responsibility. Sunopta focuses on delivering high-quality, non-genetically modified organism (GMO) ingredients to meet the growing demand for healthy and sustainable food choices. With its customer-centric approach, Sunopta prioritizes quality control and food safety to ensure consumer satisfaction. By integrating its values into the corporate philosophy, Sunopta aims to inspire trust and become a leading provider of organic and natural food solutions.
Analysts currently set an average price target of 7.98 USD for the Sunopta stock (median: 7.98 USD), implying +23.6 % versus the latest price. The consensus is based on 6 analyst ratings.
5 analysts currently rate the Sunopta stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sunopta to generate revenue of 840.07 M USD and earnings per share of 0.19 USD.
Converted at the current exchange rate, the Sunopta share trades at 5.59 EUR (6.45 USD).
The Sunopta share (SOY.TO) is listed on 5 stock exchanges, including: NASDAQ (STKL), Frankfurt (ZSK.F), München (ZSK.MU), Düsseldorf (ZSK.DU), Toronto (SOY.TO).
SunOpta Inc. is a North American company specializing in the production and distribution of organic, non-genetically modified, and specialized foods and ingredients. The company operates in multiple business segments and offers a wide range of products. The previous business activities of SunOpta Inc. were divided into three segments: Healthy Food Ingredients, Organic Ingredients, and Consumer Products. The Healthy Food Ingredients segment produces fruit and plant concentrates, plant-based protein, and fiber-rich ingredients that are widely used in the food industry. These products have a wide application in the production of fruit and vegetable juices, cereals, and other healthy foods. SunOpta is able to meet the needs of different producers, consumers, and traders as it operates in different markets and regions. Organic Ingredients provides natural, GMO-free ingredients such as fruits, nuts, and seeds. They are able to control the entire production process of their organic range, including cultivation, harvesting, processing, and packaging. These products are widely used in the food, animal feed, and natural foods industries. The Consumer Products segment produces reformed and processed foods available in supermarkets and online platforms. The range includes nut breads, fruit bars, and various organic coffee products. The globally growing demand for healthy foods and ingredients creates good growth opportunities for SunOpta. The company is expanding its capacity and product portfolio to serve the rapidly growing market. SunOpta invests millions annually in infrastructure expansion and research and development to remain competitive. As a company, SunOpta is committed to improving environmental protection in both production and the entire value chain. The company has developed environmental, health, safety, and social responsibility policies to contribute to sustainability and society. Overall, SunOpta offers a wide range of organic, non-genetically modified, specialized foods, and ingredients that appeal to conscious consumers and make a significant contribution to a healthy and sustainable diet. The company focuses on growth through constant innovation and investment to meet customer needs and strengthen its competitive position.
The expected revenue of Sunopta is 840.07 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Sunopta is 22.30 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sunopta is currently 33.75. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sunopta stock.
The price-to-sales ratio (P/S) of Sunopta is currently 0.90. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sunopta stock.
The Eulerpool Quality Score for Sunopta is 1/10.
The ISIN of Sunopta is CA8676EP1086. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Sunopta is 784556. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Sunopta is SOY.TO. The ticker symbol is used to trade Sunopta shares on the stock exchange.
Sunopta paid dividends every year for the past 0 years.
Sunopta is assigned to the 'Non-cyclical consumption' sector.
The dividends of Sunopta are distributed in USD.
Sunopta stock
Sunopta Peer Group
Sunopta Ticker
Sunopta FIGI
All fundamentals and in-depth analysis of Sunopta
Our stock analysis for Sunopta stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sunopta. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.